KCNK16 and MODY: We have identified what we believe to be the first family with MODY due to a pathogenic variant in KCNK16. This TALK-1 gain-of-function p.Leu114Pro variant increases β cell K+ efflux, resulting in membrane hyperpolarization; alters β cell Ca2+ handling; and decreases GSIS.